![Jing Rong Jean Cui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Rong Jean Cui
Fondatore presso
BLOSSOMHILL THERAPEUTICS, INC.
Patrimonio netto: 74 M $ in data 30/09/2026
Profilo
Jing Rong Jean Cui is the founder of Blossomhill Therapeutics, Inc., founded in 2020.
Dr. Jean Cui was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title of Director in 2020.
Dr. Jean Cui earned a doctorate from The Ohio State University.
Dr. Jean Cui completed undergraduate and graduate degrees at the University of Science & Technology of China.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/08/2026 | 3.973.138 ( 12,5% ) | 74 M $ | 30/09/2026 |
Posizioni attive di Jing Rong Jean Cui
| Società | Posizione | Inizio |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Fondatore | 01/06/2020 |
Precedenti posizioni note di Jing Rong Jean Cui
| Società | Posizione | Fine |
|---|---|---|
| TURG POIN | Fondatore | 15/06/2020 |
Formazione di Jing Rong Jean Cui
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
39
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
